130 related articles for article (PubMed ID: 37782156)
1. The value of multimodal magnetic resonance imaging in breast cancer and its correlation with pathological features and prognosis.
Luo Q; Yang L; Zhou X
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8397-8403. PubMed ID: 37782156
[TBL] [Abstract][Full Text] [Related]
2. [The value of DISCO and MUSE-DWI combined with prostate specific antigen density in the diagnosis and risk stratification of prostate cancer].
Chen ZQ; Zhang D; Wang Z; Song N; Ma AL; Zhang SR; Cai L
Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1461-1468. PubMed ID: 37198108
[No Abstract] [Full Text] [Related]
3. Distinguishing T1-2 and T3a tumors of rectal cancer with texture analysis and functional MRI parameters.
Sun D; Wu X; Wang L; Li G; Huang J; Li Y
Diagn Interv Radiol; 2022 May; 28(3):200-207. PubMed ID: 35748201
[TBL] [Abstract][Full Text] [Related]
4. Application of Dynamic Enhanced Magnetic Resonance Imaging Texture Analysis Combined with ADCs in Predicting Pelvic Lymph Metastasis of Prostate Cancer.
Yao L; Ding J; Li X; Yang J; Chen Z; Jia C; Duan Q
Arch Esp Urol; 2023 Aug; 76(6):383-388. PubMed ID: 37681328
[TBL] [Abstract][Full Text] [Related]
5. 3.0 T Magnetic Resonance Functional Imaging Quantitative Parameters for Differential Diagnosis of Benign and Malignant Lesions of the Breast.
Cheng X; Chen C; Xia H; Zhang L; Xu M
Cancer Biother Radiopharm; 2021 Aug; 36(6):448-455. PubMed ID: 32716710
[No Abstract] [Full Text] [Related]
6. Role of perfusion parameters on DCE-MRI and ADC values on DWMRI for invasive ductal carcinoma at 3.0 Tesla.
Liu F; Wang M; Li H
World J Surg Oncol; 2018 Dec; 16(1):239. PubMed ID: 30577820
[TBL] [Abstract][Full Text] [Related]
7. Correlation of magnetic resonance imaging quantitative parameters and apparent diffusion coefficient value with pathological breast cancer.
Wang Z; Ren GY; Yin Q; Wang Q
World J Clin Cases; 2022 Jul; 10(21):7333-7340. PubMed ID: 36158015
[TBL] [Abstract][Full Text] [Related]
8. Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study.
Incoronato M; Grimaldi AM; Cavaliere C; Inglese M; Mirabelli P; Monti S; Ferbo U; Nicolai E; Soricelli A; Catalano OA; Aiello M; Salvatore M
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1680-1693. PubMed ID: 29696443
[TBL] [Abstract][Full Text] [Related]
9. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B
Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Significance of DCE-MRI-Related Quantitative Parameters for Nasal Cavity and Sinus Tumors.
Zhang H; Li LY; Yu LY; Liu NB; Yang D; Zhang SJ; Xu JH
Altern Ther Health Med; 2023 Nov; ():. PubMed ID: 37971454
[TBL] [Abstract][Full Text] [Related]
11. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging parameters and serum tumor markers in rectal carcinoma prognosis.
Mu RQ; Lv JW; Ma CY; Ma XH; Xing D; Ma HS
World J Gastrointest Oncol; 2024 May; 16(5):1796-1807. PubMed ID: 38764818
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Multimodal Magnetic Resonance Imaging in Discriminating Between Metastatic and Non-Metastatic Pelvic Lymph Nodes in Cervical Cancer.
Xu J; Ma Y; Mei H; Wang Q
Int J Gen Med; 2022; 15():6279-6288. PubMed ID: 35911622
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of parotid gland tumours: Application of SWI combined with DWI and DCE-MRI.
Xu Z; Chen M; Zheng S; Chen S; Xiao J; Hu Z; Lu L; Yang Z; Lin D
Eur J Radiol; 2022 Jan; 146():110094. PubMed ID: 34906852
[TBL] [Abstract][Full Text] [Related]
15. The Assessment of Prostate Cancer Aggressiveness Using a Combination of Quantitative Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Zhu G; Luo J; Ouyang Z; Cheng Z; Deng Y; Guan Y; Du G; Zhao F
Cancer Manag Res; 2021; 13():5287-5295. PubMed ID: 34239327
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
[TBL] [Abstract][Full Text] [Related]
17. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
[TBL] [Abstract][Full Text] [Related]
18. Associations Between Dynamic Contrast Enhanced Magnetic Resonance Imaging and Clinically Relevant Histopathological Features in Breast Cancer: A Multicenter Analysis.
Surov A; Kim JY; Aiello M; Huang W; Yankeelov TE; Wienke A; Pech M
In Vivo; 2022; 36(1):398-408. PubMed ID: 34972741
[TBL] [Abstract][Full Text] [Related]
19. Discrimination between benign and malignant lung lesions using volumetric quantitative dynamic contrast-enhanced MRI.
Wei F; Weidong F; Wenming Z; Lei H; Xiaosan C; Zhongliang M; Qianyun L; Huashan L
Curr Med Imaging; 2023 Jul; ():. PubMed ID: 37497704
[TBL] [Abstract][Full Text] [Related]
20. Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer.
Liang X; Chen X; Yang Z; Liao Y; Wang M; Li Y; Fan W; Dai Z; Zhang Y
BMC Cancer; 2022 Dec; 22(1):1250. PubMed ID: 36460972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
